Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Latimer

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|October 19, 2013
Adjusting overall survival for treatment switches: commonly used methods and practical applicationClaire Watkins, Xin Huang, Nicholas Latimer, et al.
Pharmacoeconomics|November 11, 2010
Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitorsNicholas Latimer, Joanne Lord, Robert L Grant, et al.
BMC Medical Research Methodology|January 13, 2011
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation studyJames P Morden, Paul C Lambert, Nicholas Latimer, et al.
BMJ (Clinical Research Ed.)|July 16, 2009
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritisNicholas Latimer, Joanne Lord, Robert L Grant, et al.
Trials|January 28, 2015
Clinical and cost effectiveness of computer treatment for aphasia post stroke (Big CACTUS): study protocol for a randomised controlled trialRebecca Palmer, Cindy Cooper, Pam Enderby, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2019
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological PapersAbualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 14, 2022
Propensity Score and Instrumental Variable Techniques in Observational Transplantation Studies: An Overview and Worked Example Relating to Pre-Transplant Cardiac ScreeningAilish Nimmo, Nicholas Latimer, Gabriel C Oniscu, et al.
Statistics in Medicine|November 7, 2023
Modeling the multi-state natural history of rare diseases with heterogeneous individual patient data: A simulation studyJonathan Broomfield, Keith R Abrams, Suzanne Freeman, et al.
Pharmacoeconomics|May 19, 2019
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival ExtrapolationsMario J N M Ouwens, Pralay Mukhopadhyay, Yiduo Zhang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 12, 2019
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for ImprovementHelen Bell Gorrod, Ben Kearns, John Stevens, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|October 19, 2013
Adjusting overall survival for treatment switches: commonly used methods and practical applicationClaire Watkins, Xin Huang, Nicholas Latimer, et al.
Pharmacoeconomics|November 11, 2010
Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitorsNicholas Latimer, Joanne Lord, Robert L Grant, et al.
BMC Medical Research Methodology|January 13, 2011
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation studyJames P Morden, Paul C Lambert, Nicholas Latimer, et al.
BMJ (Clinical Research Ed.)|July 16, 2009
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritisNicholas Latimer, Joanne Lord, Robert L Grant, et al.
Trials|January 28, 2015
Clinical and cost effectiveness of computer treatment for aphasia post stroke (Big CACTUS): study protocol for a randomised controlled trialRebecca Palmer, Cindy Cooper, Pam Enderby, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2019
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological PapersAbualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 14, 2022
Propensity Score and Instrumental Variable Techniques in Observational Transplantation Studies: An Overview and Worked Example Relating to Pre-Transplant Cardiac ScreeningAilish Nimmo, Nicholas Latimer, Gabriel C Oniscu, et al.
Statistics in Medicine|November 7, 2023
Modeling the multi-state natural history of rare diseases with heterogeneous individual patient data: A simulation studyJonathan Broomfield, Keith R Abrams, Suzanne Freeman, et al.
Pharmacoeconomics|May 19, 2019
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival ExtrapolationsMario J N M Ouwens, Pralay Mukhopadhyay, Yiduo Zhang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 12, 2019
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for ImprovementHelen Bell Gorrod, Ben Kearns, John Stevens, et al.
Pageof 3